溶解性 | DMSO ≥90mg/mL Water <1.2mg/mL Ethanol ≥30mg/mL |
存贮条件 | 储存温度-20°C |
产品介绍 | Danusertib (PHA-739358)是一种Aurora kinase抑制剂,作用于Aurora A/B/C时IC50为13 nM/79 nM/61 nM,适度有效作用于Abl, TrkA, c-RET和FGFR1,对Lck, VEGFR2/3, c-Kit, CDK2等作用效果稍弱。 |
备注 | Danusertib (PHA-739358) is an Aurora kinase inhibitor for Aurora A/B/C with IC50 of 13 nM/79 nM/61 nM, modestly potent to Abl, TrkA, c-RET and FGFR1, and less potent to Lck, VEGFR2/3, c-Kit, CDK2, etc. Phase 2. |
别名 | PHA739358;达鲁舍替; N-[5-((2R)-2-甲氧基-2-苯基乙酰基)-1,4,5,6-四氢吡咯并[3,4-c]吡唑-3-基]-4-(4-甲基哌嗪-1-基)苯甲酰胺;PHA-739358; PHA739358; PHA 739358;N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide |